This article will address the topic of GSX2, which is of great relevance and topicality in the _var2 field. Its impact on society will be analyzed, as well as its implications on _var3. In addition, different perspectives and approaches related to GSX2 will be considered, with the aim of providing a comprehensive and complete vision on this topic. By reviewing updated and contrasted information, the aim is to offer the reader a clear and objective vision of GSX2, as well as the possible consequences that its development may generate in the future.
GS homeobox 2 (GSX2) is a protein encoded by a gene of the same name, located on chromosome 4 in humans,[5] and on chromosome 5 in mice.[6]
It is especially important to regulating the development of the brain, particularly during embryonic development.[7] Mutations have been linked to a variety of neurological disorders that can cause intellectual disability, dystonia (difficulty with movement) and seizures.[8]
GSX2 is a polypeptide chain consisting of 304 amino acids, with a molecular weight of 32,031.[9]
GSX2 is a homeobox transcription factor essential for mammalian forebrain development, particularly in specifying and patterning the basal ganglia.[10][7] It binds specific DNA sequences, crucial for dorsal-ventral patterning of the telencephalon and specifying neural progenitors in the ventral forebrain.[11][12]
GSX2 acts within a temporal framework, initially guiding the specification of striatal projection neurons during early lateral ganglionic eminence (LGE) neurogenesis, and later supporting olfactory bulb interneuron development.[13] Mutations in GSX2 have been linked to basal ganglia dysgenesis in humans, resulting in severe neurological symptoms, including dystonia and intellectual impairment.[10]
GSX2 is highly expressed in neural progenitors within the ganglionic eminences, precursors to the basal ganglia and olfactory structures. It promotes neurogenesis while inhibiting differentiation into oligodendrocytes, a type of glial cell in the central nervous system.[7]
Mutations in GSX2 have been linked to severe neurodevelopmental disorders characterized by specific brain malformations. This includes cases of basal ganglia agenesis, leading to symptoms such as a slowly progressive decline in neurologic function, dystonia, and intellectual impairment.[8]
A single nucleotide polymorphism and missense mutation in GSX2, rs1578004339, has been found to be a pathogenic cause of diencephalic-mesencephalic junction dysplasia syndrome, a neurodevelopmental disorder characterised by severe intellectual disability and seizures.[8]